| Teresa Dolan, | |
|
1800 E Park Ave, C/o Mount Nittany Medical Center, State College, PA 16803-6701 | |
| (814) 234-6110 | |
| Not Available |
| Full Name | Teresa Dolan |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1800 E Park Ave, State College, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245248053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD420744 (Pennsylvania) | Primary |
| Entity Name | Whc Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700154226 PECOS PAC ID: 6103093513 Enrollment ID: O20120125000252 |
News Archive
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.
Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today the pricing of its initial public offering of 6,500,000 shares of common stock at a price to the public of $8.00 per share.
The National Institute of Dental and Craniofacial Research (NIDCR), one of the National Institutes of Health (NIH), has issued a two-year $912,943 grant to biopharmaceutical company Selenium, Ltd. to support the development of antimicrobial dental devices and water lines. In the two-part grant the NIH has approved $492,972 for year one and $419,971 for year two dependent on achieving year one objectives.
New study by Cancer Science Institute of Singapore at NUS show that the protein is produced as an immune response and requires the tumour suppressor RUNX3.
Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Dolan, 500 University Dr, Hershey, PA 17033-2360 Ph: () - | Teresa Dolan, 1800 E Park Ave, C/o Mount Nittany Medical Center, State College, PA 16803-6701 Ph: (814) 234-6110 |
News Archive
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.
Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today the pricing of its initial public offering of 6,500,000 shares of common stock at a price to the public of $8.00 per share.
The National Institute of Dental and Craniofacial Research (NIDCR), one of the National Institutes of Health (NIH), has issued a two-year $912,943 grant to biopharmaceutical company Selenium, Ltd. to support the development of antimicrobial dental devices and water lines. In the two-part grant the NIH has approved $492,972 for year one and $419,971 for year two dependent on achieving year one objectives.
New study by Cancer Science Institute of Singapore at NUS show that the protein is produced as an immune response and requires the tumour suppressor RUNX3.
Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.
› Verified 6 days ago
Jason Ferderber, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Gatesburg Rd Ste 200, State College, PA 16803 Phone: 814-237-4321 Fax: 814-235-0484 | |
Dr. Kevin Allan Mishock, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, Mount Nittany Medical Center, State College, PA 16803 Phone: 814-234-6110 | |
Dr. Christine Louise Tichansky, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Radnor Rd, Ste 100, State College, PA 16801 Phone: 814-231-7868 Fax: 814-238-4169 | |
Dr. Kasandra Ann Botti, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6110 | |
Dr. Ryan Michael Burton, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6110 | |
Dr. Mina Salib, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 University Dr, State College, PA 16801 Phone: 814-375-4045 |